0001567619-20-001041.txt : 20200114
0001567619-20-001041.hdr.sgml : 20200114
20200114175030
ACCESSION NUMBER: 0001567619-20-001041
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200110
FILED AS OF DATE: 20200114
DATE AS OF CHANGE: 20200114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lanfear Dennis M
CENTRAL INDEX KEY: 0001420822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36721
FILM NUMBER: 20526839
MAIL ADDRESS:
STREET 1: C/O INSMED INCORPORATED
STREET 2: 8720 STONY POINT PKWY, SUITE 200
CITY: RICHMOND
STATE: VA
ZIP: 23235
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Coherus BioSciences, Inc.
CENTRAL INDEX KEY: 0001512762
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273615821
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O DENNIS M. LANFEAR
STREET 2: 333 TWIN DOLPHIN DR, SUITE 600
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: (650) 649-3530
MAIL ADDRESS:
STREET 1: C/O DENNIS M. LANFEAR
STREET 2: 333 TWIN DOLPHIN DR, SUITE 600
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: BioGenerics, Inc.
DATE OF NAME CHANGE: 20110210
4
1
doc1.xml
FORM 4
X0306
4
2020-01-10
0
0001512762
Coherus BioSciences, Inc.
CHRS
0001420822
Lanfear Dennis M
COHERUS BIOSCIENCES, INC.
333 TWIN DOLPHIN DRIVE, SUITE 600
REDWOOD CITY
CA
94065
1
1
0
0
President & CEO
Common Stock, $0.0001 par value
2020-01-10
4
A
0
59763
0.00
A
184780
D
Common Stock, $0.0001 par value
2020-01-10
4
F
0
21516
17.73
D
163264
D
Common Stock, $0.0001 par value
446684
I
By Trust
Common Stock, $0.0001 par value
86965
I
By LLC
Stock Option (Right to Buy)
17.73
2020-01-10
4
A
0
500000
0.00
A
2030-01-10
Common Stock
500000
500000
D
These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee.
These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President.
The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
/s/ Jean-Frederic Viret, as Attorney-in-Fact for Dennis M. Lanfear
2020-01-14